Page last updated: 2024-09-04

san 32-468 and alprenolol

san 32-468 has been researched along with alprenolol in 1 studies

Compound Research Comparison

Studies
(san 32-468)
Trials
(san 32-468)
Recent Studies (post-2010)
(san 32-468)
Studies
(alprenolol)
Trials
(alprenolol)
Recent Studies (post-2010) (alprenolol)
6101,14612159

Protein Interaction Comparison

ProteinTaxonomysan 32-468 (IC50)alprenolol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.0031
Beta-1 adrenergic receptorHomo sapiens (human)0.007
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.63
Beta-3 adrenergic receptorHomo sapiens (human)0.0023
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0049
Squalene synthaseRattus norvegicus (Norway rat)4.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H1

Reviews

1 review(s) available for san 32-468 and alprenolol

ArticleYear
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship

1988